Recalled Diamond Shruumz Linked to Three Deaths, 175 Illnesses, FDA Reports
FDA has identified traces of schedule I controlled substances, prescription drugs and other potentially harmful ingredients in recalled Diamond Shruumz microdosing edibles.
FDA has identified traces of schedule I controlled substances, prescription drugs and other potentially harmful ingredients in recalled Diamond Shruumz microdosing edibles.
Side effects of Mounjaro caused cyclical vomiting that required emergency medical treatment, lawsuit claims.
Wegovy lawsuit claims the diet drug manufacturer minimized the risk of gastroparesis symptoms on the warning label, failing to inform doctors and patients about the long term side effects.
Researchers suggest that magnesium sulfate taken by expecting mothers may prevent preterm cerebral palsy by stabilizing blood flow to the fetus's brain.
Nearly 40 illnesses have been linked to recalled Shruumz mushroom products, which may cause cause seizures, abnormal heart rates, nausea and vomiting.
The exact cause of the illnesses linked to side effects Diamond Shruumz products has not yet been determined.
Lawsuit claims Novo Nordisk failed to warn that the risk of Wegovy gastroparesis side effects was dose-specific, meaning the higher the dose, the more likely stomach paralysis would occur.
Lawsuit indicates that side effect of Wegovy caused a Kentucky woman to develop stomach paralysis and a bowel obstruction, which resulted in multiple days of hospitaliation and left her with long-term gastrointestinal damage
Necrotizing pancreatitis is caused by the death of pancreas tissue, resulting in infections and lower pancreas functionality which can limit digestion.
Lawsuit indicates that Novo Nordisk fails to adequately disclose serious risks, indicating some doctors estimate 10% of users discontinue due the severity of the Ozempic side effects.